VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of ...

Under the terms of the LOI, the Company, subject to completion of satisfactory due diligence and other customary conditions, would acquire all of the Inka Shares in exchange for such number of common ...

Aria Intelligent Solutions offers tailored strategies to navigate complex market challenges, boosting efficiency and ...

Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE® Rights ex-US Sale of GOLIKE® Rights Outside the U.S. to Nutrisens Relief to Focus on R&D of Pipeline Assets and Licensing for ...

The Dome Shaver Pro has a blade pad containing 5 Triple-Track Blade Heads in a curved configuration, meant to hug the natural ...

A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...

The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s ...

Arab Health 2025, the premier event for the medical sector in the Near and Middle East, is set to host 89 French healthcare ...

Heraeus Precious Metals announced that it has acquired Umicore’s Platinum Active Pharmaceutical Ingredient (API) business ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...